MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202617063445 A) filed by Vertex Pharmaceuticals Incorporated on May 19, 2026, for Heteroaryl Compounds For The Treatment Of Pain.
Inventors include Miller, Mark, Thomas; Pinder, Joanne, Louise; Knegtel, Ronald, Marcellus; Mui, James, Jun, Bon; Beck, Elizabeth, Mary; Chudyk, Ewa, Iwona; Simpson, Iain; Slochower, David, Robert; Neubert, Timothy, Donald; Hurley, Dennis, James; Scharf, Adam; Patel, Urvi; Hadida Ruah, Sara, Sabina; Zhou, Jinglan; Ghirmai, Senait, G.; Valiulin, Roman, Askatovich; Webb, Peter; Aertgeerts, Kathleen; Kintzer, Alexander, Frederick; Cleveland, Thomas; Chau, Jaclyn; Mccartney, Jason; Jacques, Reece; Keilly, Shazia; Salman, Alan, Alessandro; Austin, James, Robert; Sousa, Bruno, Artur; Pullin, Robert, David, Charles; Vogel, Carl, Victor; Dodd, James; and Storck, Pierre-Henri.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.
Disclaimer: Curated by HT Syndication.
